|
There was an allegation of questionable elecsys anti-hav ii results for 2 patients on a cobas e 411 analyzer (rack system).Patient 1: the initial result was 0.976 coi (reactive).The confirmation results for the sample (using the abbott architect method) were nonreactive.The anti-hav igm result was 0.10, and the anti-hav igg result was 0.12.The units of measure for the confirmation results were not provided.Patient 2: the reporter stated that the patient's samples were repeatedly reactive.On (b)(6) 2024, the patient's result was 0.966 coi (reactive).On (b)(6) 2025, a new sample was obtained and the result was 0.955 coi (reactive).The confirmation results for the (b)(6) 2025 sample (using the abbott architect method) were nonreactive.The anti-hav igm result was 0.09, and the anti-hav igg result was 0.28.The units of measure for the confirmation results were not provided.
|
|
The calibration was last performed on 28-nov-2024.No additional calibration data was provided.The provided qc data in dec-2024, mar-2025, and apr-2025 were within specifications.The calibration lot from nov-2024 was used.The samples were requested for investigation, but are no longer available.Based on the calibration and qc data, the reagent performs within specifications.The product labeling states: "for diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." "analytical specificity / cross-reactivity: the specificity of the elecsys anti-hav ii assay on the cobas e 601 immunoassay analyzer was evaluated by testing a total of 120 samples (native human serum and plasma pools) positive for antibodies to a variety of disease states (ana, cmv, ebv, hbv, hcv, hiv, hsv, mumps/rubeola, parvovirus b19, rubella, toxoplasmosis gondii and treponema pallidum).Samples were measured with elecsys anti-hav assay and elecsys anti-hav ii assay on the cobas e 601 immunoassay analyzer.No discrepant results or cross-reactivity with antibodies to other infectious agents were found." the investigation did not identify a product problem.
|